Brief: TG Therapeutics Announces European Launch of BRIUMVI (ublituximab-xiiy)
26/02/2024 12:02
Feb 26 (Reuters) - TG Therapeutics Inc TGTX.O :
* TG THERAPEUTICS ANNOUNCES EUROPEAN LAUNCH OF BRIUMVI®
(UBLITUXIMAB-XIIY)
* TG THERAPEUTICS INC - WILL RECEIVE A MILESTONE PAYMENT OF
$12.5
MILLION FOR FIRST LAUNCH OF BRIUMVI IN A EUROPEAN COUNTRY
Source text for Eikon: ID:nGNX4ygTWp
Further company coverage: TGTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TG Therapeutics
See all newsTG Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tg Therapeutics Reports Second Quarter 2026 Financial Results And Raises Briumvi® Revenue Guidance
TG Therapeutics Q2 product revenue rises 70% on BRIUMVI sales
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj